Global Lou Gehrigs Disease Market 2020 - Research Report, Demand, Price, By Application, Region and Forecast to 2026

 Published Date : Oct-2018   |    Format :PDF |    Number of Pages : 100   |    Publisher : e-Market Research

This report studies the global market size of Lou Gehrigs Disease in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Lou Gehrigs Disease in these regions.
This research report categorizes the global Lou Gehrigs Disease market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Amyotrophic lateral sclerosis (ALS), also known as motor neurone disease (MND), or Lou Gehrig's disease, is a specific disease which causes the death of neurons controlling voluntary muscles. Some also use the term motor neuron disease for a group of conditions of which ALS is the most common.
In 2017, the global Lou Gehrigs Disease market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Lou Gehrigs Disease market based on company, product type, application and key regions.

The various contributors involved in the value chain of Lou Gehrigs Disease include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Lou Gehrigs Disease include
    AB Science
    Avicena Group
    Biogen
    BrainStorm Therapeutics
    Covis Pharmaceutical Inc.
    Cytokinetics Inc.
    Eisai Co. Ltd.
    GlaxoSmithKline plc.
    Ionis Pharmaceuticals, Inc.
    Mitsubishi Tanabe Pharma Corp.
    Neuralstem Inc.
    Neuraltus Pharmaceuticals Inc.
    Newron Pharmaceuticals S.p.A.
    Nutra Pharma Corp.
    Pharnext SAS
    Q-Therapeutics Inc.

Market Size Split by Type
    Riluzole
    Edaravone (Radicava)
Market Size Split by Application
    Hospital Pharmacies
    Retail & Online Pharmacie

Market size split by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Lou Gehrigs Disease market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
    To understand the structure of Lou Gehrigs Disease market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Lou Gehrigs Disease manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Lou Gehrigs Disease with respect to individual growth trends, future prospects, and their contribution to the total market.
    To project the value and volume of Lou Gehrigs Disease submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Lou Gehrigs Disease are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Lou Gehrigs Disease market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Study Coverage
    1.1  Lou Gehrigs Disease Product
    1.2 Key Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Lou Gehrigs Disease Market Size Growth Rate by Type
        1.4.2 Riluzole
        1.4.3 Edaravone (Radicava)
    1.5 Market by Application
        1.5.1 Global Lou Gehrigs Disease Market Size Growth Rate by Application
        1.5.2 Hospital Pharmacies
        1.5.3 Retail & Online Pharmacie
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Lou Gehrigs Disease Market Size
        2.1.1 Global Lou Gehrigs Disease Revenue 2016-2025
        2.1.2 Global Lou Gehrigs Disease Sales 2016-2025
    2.2 Lou Gehrigs Disease Growth Rate by Regions
        2.2.1 Global Lou Gehrigs Disease Sales by Regions
        2.2.2 Global Lou Gehrigs Disease Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Lou Gehrigs Disease Sales by Manufacturers
        3.1.1 Lou Gehrigs Disease Sales by Manufacturers
        3.1.2 Lou Gehrigs Disease Sales Market Share by Manufacturers
        3.1.3 Global Lou Gehrigs Disease Market Concentration Ratio (CR5 and HHI)
    3.2 Lou Gehrigs Disease Revenue by Manufacturers
        3.2.1 Lou Gehrigs Disease Revenue by Manufacturers (2016-2018)
        3.2.2 Lou Gehrigs Disease Revenue Share by Manufacturers (2016-2018)
    3.3 Lou Gehrigs Disease Price by Manufacturers
    3.4 Lou Gehrigs Disease Manufacturing Base Distribution, Product Types
        3.4.1 Lou Gehrigs Disease Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Lou Gehrigs Disease Product Category
        3.4.3 Date of International Manufacturers Enter into Lou Gehrigs Disease  Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
    4.1 Global Lou Gehrigs Disease Sales by Type
    4.2 Global Lou Gehrigs Disease Revenue by Type
    4.3 Lou Gehrigs Disease Price by Type

5 Breakdown Data by Application
    5.1 Overview
    5.2 Global Lou Gehrigs Disease Breakdown Data by Application

6 North America
    6.1 North America Lou Gehrigs Disease by Countries
        6.1.1 North America Lou Gehrigs Disease Sales by Countries
        6.1.2 North America Lou Gehrigs Disease Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Lou Gehrigs Disease by Type
    6.3 North America Lou Gehrigs Disease by Application
    6.4 North America Lou Gehrigs Disease by Company

7 Europe
    7.1 Europe Lou Gehrigs Disease by Countries
        7.1.1 Europe Lou Gehrigs Disease Sales by Countries
        7.1.2 Europe Lou Gehrigs Disease Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Lou Gehrigs Disease by Type
    7.3 Europe Lou Gehrigs Disease by Application
    7.4 Europe Lou Gehrigs Disease by Company

8 Asia Pacific
    8.1 Asia Pacific Lou Gehrigs Disease by Countries
        8.1.1 Asia Pacific Lou Gehrigs Disease Sales by Countries
        8.1.2 Asia Pacific Lou Gehrigs Disease Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Lou Gehrigs Disease by Type
    8.3 Asia Pacific Lou Gehrigs Disease by Application
    8.4 Asia Pacific Lou Gehrigs Disease by Company

9 Central & South America
    9.1 Central & South America Lou Gehrigs Disease by Countries
        9.1.1 Central & South America Lou Gehrigs Disease Sales by Countries
        9.1.2 Central & South America Lou Gehrigs Disease Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Lou Gehrigs Disease by Type
    9.3 Central & South America Lou Gehrigs Disease by Application
    9.4 Central & South America Lou Gehrigs Disease by Company

10 Middle East and Africa
    10.1 Middle East and Africa Lou Gehrigs Disease by Countries
        10.1.1 Middle East and Africa Lou Gehrigs Disease Sales by Countries
        10.1.2 Middle East and Africa Lou Gehrigs Disease Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Lou Gehrigs Disease by Type
    10.3 Middle East and Africa Lou Gehrigs Disease by Application
    10.4 Middle East and Africa Lou Gehrigs Disease by Company

11 Company Profiles
    11.1 AB Science
        11.1.1 AB Science Company Details
        11.1.2 Company Description
        11.1.3 Sales, Revenue and Gross Margin of Lou Gehrigs Disease
        11.1.4 Lou Gehrigs Disease Product Description
        11.1.5 Recent Development
    11.2 Avicena Group
        11.2.1 Avicena Group Company Details
        11.2.2 Company Description
        11.2.3 Sales, Revenue and Gross Margin of Lou Gehrigs Disease
        11.2.4 Lou Gehrigs Disease Product Description
        11.2.5 Recent Development
    11.3 Biogen
        11.3.1 Biogen Company Details
        11.3.2 Company Description
        11.3.3 Sales, Revenue and Gross Margin of Lou Gehrigs Disease
        11.3.4 Lou Gehrigs Disease Product Description
        11.3.5 Recent Development
    11.4 BrainStorm Therapeutics
        11.4.1 BrainStorm Therapeutics Company Details
        11.4.2 Company Description
        11.4.3 Sales, Revenue and Gross Margin of Lou Gehrigs Disease
        11.4.4 Lou Gehrigs Disease Product Description
        11.4.5 Recent Development
    11.5 Covis Pharmaceutical Inc.
        11.5.1 Covis Pharmaceutical Inc. Company Details
        11.5.2 Company Description
        11.5.3 Sales, Revenue and Gross Margin of Lou Gehrigs Disease
        11.5.4 Lou Gehrigs Disease Product Description
        11.5.5 Recent Development
    11.6 Cytokinetics Inc.
        11.6.1 Cytokinetics Inc. Company Details
        11.6.2 Company Description
        11.6.3 Sales, Revenue and Gross Margin of Lou Gehrigs Disease
        11.6.4 Lou Gehrigs Disease Product Description
        11.6.5 Recent Development
    11.7 Eisai Co. Ltd.
        11.7.1 Eisai Co. Ltd. Company Details
        11.7.2 Company Description
        11.7.3 Sales, Revenue and Gross Margin of Lou Gehrigs Disease
        11.7.4 Lou Gehrigs Disease Product Description
        11.7.5 Recent Development
    11.8 GlaxoSmithKline plc.
        11.8.1 GlaxoSmithKline plc. Company Details
        11.8.2 Company Description
        11.8.3 Sales, Revenue and Gross Margin of Lou Gehrigs Disease
        11.8.4 Lou Gehrigs Disease Product Description
        11.8.5 Recent Development
    11.9 Ionis Pharmaceuticals, Inc.
        11.9.1 Ionis Pharmaceuticals, Inc. Company Details
        11.9.2 Company Description
        11.9.3 Sales, Revenue and Gross Margin of Lou Gehrigs Disease
        11.9.4 Lou Gehrigs Disease Product Description
        11.9.5 Recent Development
    11.10 Mitsubishi Tanabe Pharma Corp.
        11.10.1 Mitsubishi Tanabe Pharma Corp. Company Details
        11.10.2 Company Description
        11.10.3 Sales, Revenue and Gross Margin of Lou Gehrigs Disease
        11.10.4 Lou Gehrigs Disease Product Description
        11.10.5 Recent Development
    11.11 Neuralstem Inc.
    11.12 Neuraltus Pharmaceuticals Inc.
    11.13 Newron Pharmaceuticals S.p.A.
    11.14 Nutra Pharma Corp.
    11.15 Pharnext SAS
    11.16 Q-Therapeutics Inc.

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    12.1 Market Opportunities and Drivers
    12.2 Market Challenges
    12.3 Market Risks/Restraints
    12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
    13.1 Value Chain Analysis
        13.1.1 Typical Suppliers of Key Lou Gehrigs Disease Raw Material
        13.1.2 Lou Gehrigs Disease Customers
    13.2 Sales Channels Analysis
        13.2.1 Sales Channels Analysis
        13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            15.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Author Details
    15.3 Disclaimer



List of Tables and Figures

    Figure Picture of Lou Gehrigs Disease
    Figure Global Lou Gehrigs Disease Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
    Figure Global Lou Gehrigs Disease Production Market Share by Types (Product Category) in 2017
    Figure Riluzole Product Picture
    Table Major Manufacturers of Riluzole
    Figure Edaravone (Radicava) Product Picture
    Table Major Manufacturers of Edaravone (Radicava)
    Table Global Lou Gehrigs Disease Market Size Growth Rate by Application 2018-2025 (K Units)
    Figure Hospital Pharmacies
    Figure Retail & Online Pharmacie
    Figure Lou Gehrigs Disease Report Years Considered
    Figure Global Lou Gehrigs Disease Market Size 2016-2025 (Million US$)
    Figure Global Lou Gehrigs Disease Sales 2016-2025 (K Units)
    Table Global Lou Gehrigs Disease Market Size by Regions 2016-2025 (K Units) & (Million US$)
    Table Global Lou Gehrigs Disease Sales by Regions 2016-2025 (K Units)
    Table Global Lou Gehrigs Disease Sales Market Share by Regions 2016-2025
    Figure Global Lou Gehrigs Disease Sales Market Share by Regions 2016-2025
    Figure 2017 Global Lou Gehrigs Disease Sales Market Share by Regions
    Table Global Lou Gehrigs Disease Revenue by Regions 2016-2025 (Million US$)
    Table Global Lou Gehrigs Disease Revenue Market Share by Regions 2016-2025
    Figure Global Lou Gehrigs Disease Revenue Market Share by Regions 2016-2025
    Figure 2017 Global Lou Gehrigs Disease Revenue Market Share by Regions
    Table Global Lou Gehrigs Disease Sales by Manufacturers (2016-2018) (K Units)
    Table Global Lou Gehrigs Disease Sales Share by Manufacturers (2016-2018)
    Figure Global Lou Gehrigs Disease Sales Share by Manufacturers in 2017
    Table Lou Gehrigs Disease Revenue by Manufacturers (2016-2018) (Million US$)
    Table Lou Gehrigs Disease Revenue Share by Manufacturers (2016-2018)
    Figure Lou Gehrigs Disease Value Share by Manufacturers in 2017
    Table Global Lou Gehrigs Disease Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Manufacturers Lou Gehrigs Disease Price (2016-2018) (USD/Unit)
    Table Lou Gehrigs Disease Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Lou Gehrigs Disease Product Category
    Table Date of International Manufacturers Enter into Lou Gehrigs Disease Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Lou Gehrigs Disease Sales by Type (2016-2025) (K Units)
    Table Global Lou Gehrigs Disease Sales Share by Type (2016-2025)
    Figure Global Lou Gehrigs Disease Sales Market Share by Type (2016-2025)
    Figure Global Lou Gehrigs Disease Sales Market Share by Type in 2017
    Table Global Lou Gehrigs Disease Revenue by Type (2016-2025) (Million US$)
    Table Global Lou Gehrigs Disease Revenue Share by Type (2016-2025)
    Figure Global Lou Gehrigs Disease Revenue Market Share by Type (2016-2025)
    Figure Global Lou Gehrigs Disease Revenue Market Share by Type in 2017
    Table Lou Gehrigs Disease Price by Type 2013-2018 (USD/Unit)
    Table Global Lou Gehrigs Disease Sales by Application (2016-2025) (K Units)
    Table Global Lou Gehrigs Disease Sales Share by Application (2016-2025)
    Figure Global Sales Lou Gehrigs Disease Market Share by Application (2016-2025)
    Figure Global Sales Lou Gehrigs Disease Market Share by Application (2016-2025)
    Figure North America Lou Gehrigs Disease Sales Growth Rate 2016-2025 (K Units)
    Figure North America Lou Gehrigs Disease Revenue Growth Rate 2016-2025 (Million US$)
    Table North America Lou Gehrigs Disease Sales by Countries (2016-2025) (K Units)
    Table North America Lou Gehrigs Disease Sales Market Share by Countries (2016-2025)
    Figure 2017 North America Lou Gehrigs Disease Sales Market Share by Countries
    Table North America Lou Gehrigs Disease Revenue by Countries (2016-2025) (Million US$)
    Table North America Lou Gehrigs Disease Revenue Market Share by Countries (2016-2025)
    Figure 2017 North America Lou Gehrigs Disease Revenue Market Share by Countries
    Figure United States Lou Gehrigs Disease Sales Growth Rate (2016-2025) (K Units)
    Figure United States Lou Gehrigs Disease Revenue Growth Rate (2016-2025) (Million US$)
    Figure Canada Lou Gehrigs Disease Sales Growth Rate (2016-2025) (K Units)
    Figure Canada Lou Gehrigs Disease Revenue Growth Rate (2016-2025) (Million US$)
    Figure Mexico Lou Gehrigs Disease Sales Growth Rate (2016-2025) (K Units)
    Figure Mexico Lou Gehrigs Disease Revenue Growth Rate (2016-2025) (Million US$)
    Table North America Lou Gehrigs Disease Sales by Type (2016-2025) (K Units)
    Table North America Lou Gehrigs Disease Sales Market Share by Type (2016-2025)
    Figure 2017 North America Lou Gehrigs Disease Market Share by Type
    Table North America Lou Gehrigs Disease Sales by Application (2016-2025) (K Units)
    Table North America Lou Gehrigs Disease Sales Market Share by Application (2016-2025)
    Figure 2017 North America Lou Gehrigs Disease Market Share by Application
    Table North America Lou Gehrigs Disease Sales by Company (2016-2018) (K Units)
    Table North America Lou Gehrigs Disease Sales Market Share by Company (2016-2018)
    Figure North America Lou Gehrigs Disease Sales Market Share by Company in 2017
    Figure Europe Lou Gehrigs Disease Sales Growth Rate 2016-2025 (K Units)
    Figure Europe Lou Gehrigs Disease Revenue Growth Rate 2016-2025 (Million US$)
    Table Europe Lou Gehrigs Disease Sales by Countries (2016-2025) (K Units)
    Table Europe Lou Gehrigs Disease Sales Market Share by Countries (2016-2025)
    Figure 2017 Europe Lou Gehrigs Disease Sales Market Share by Countries
    Table Europe Lou Gehrigs Disease Revenue by Countries (2016-2025) (Million US$)
    Table Europe Lou Gehrigs Disease Revenue Market Share by Countries (2016-2025)
    Figure 2017 Europe Lou Gehrigs Disease Revenue Market Share by Countries
    Figure Germany Lou Gehrigs Disease Sales Growth Rate (2016-2025) (K Units)
    Figure Germany Lou Gehrigs Disease Revenue Growth Rate (2016-2025) (K Units)
    Figure France Lou Gehrigs Disease Sales Growth Rate (2016-2025) (K Units)
    Figure France Lou Gehrigs Disease Revenue Growth Rate (2016-2025) (K Units)
    Figure UK Lou Gehrigs Disease Sales Growth Rate (2016-2025) (K Units)
    Figure UK Lou Gehrigs Disease Revenue Growth Rate (2016-2025) (Million US$)
    Figure Italy Lou Gehrigs Disease Sales Growth Rate (2016-2025) (K Units)
    Figure Italy Lou Gehrigs Disease Revenue Growth Rate (2016-2025) (Million US$)
    Figure Russia Lou Gehrigs Disease Sales Growth Rate (2016-2025) (K Units)
    Figure Russia Lou Gehrigs Disease Revenue Growth Rate (2016-2025) (Million US$)
    Table Europe Lou Gehrigs Disease Sales by Type (2016-2025) (K Units)
    Table Europe Lou Gehrigs Disease Sales Market Share by Type (2016-2025)
    Figure 2017 Europe Lou Gehrigs Disease Market Share by Type
    Table Europe Lou Gehrigs Disease Sales by Application (2016-2025) (K Units)
    Table Europe Lou Gehrigs Disease Sales Market Share by Application (2016-2025)
    Figure 2017 Europe Lou Gehrigs Disease Market Share by Application
    Table Europe Lou Gehrigs Disease Sales by Company (2016-2018) (K Units)
    Table Europe Lou Gehrigs Disease Sales Market Share by Company (2016-2018)
    Figure Europe Lou Gehrigs Disease Sales Market Share by Company in 2017
    Figure Asia Pacific Lou Gehrigs Disease Sales Growth Rate 2016-2025 (K Units)
    Figure Asia Pacific Lou Gehrigs Disease Revenue Growth Rate 2016-2025 (Million US$)
    Table Asia Pacific Lou Gehrigs Disease Sales by Countries (2016-2025) (K Units)
    Table Asia Pacific Lou Gehrigs Disease Sales Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Lou Gehrigs Disease Sales Market Share by Countries
    Table Asia Pacific Lou Gehrigs Disease Revenue by Countries (2016-2025) (Million US$)
    Table Asia Pacific Lou Gehrigs Disease Revenue Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Lou Gehrigs Disease Revenue Market Share by Countries
    Figure China Lou Gehrigs Disease Sales Growth Rate (2016-2025) (K Units)
    Figure China Lou Gehrigs Disease Revenue Growth Rate (2016-2025) (Million US$)
    Figure Japan Lou Gehrigs Disease Sales Growth Rate (2016-2025) (K Units)
    Figure Japan Lou Gehrigs Disease Revenue Growth Rate (2016-2025) (Million US$)
    Figure Korea Lou Gehrigs Disease Sales Growth Rate (2016-2025) (K Units)
    Figure Korea Lou Gehrigs Disease Revenue Growth Rate (2016-2025) (Million US$)
    Figure India Lou Gehrigs Disease Sales Growth Rate (2016-2025) (K Units)
    Figure India Lou Gehrigs Disease Revenue Growth Rate (2016-2025) (Million US$)
    Figure Australia Lou Gehrigs Disease Sales Growth Rate (2016-2025) (K Units)
    Figure Australia Lou Gehrigs Disease Revenue Growth Rate (2016-2025) (Million US$)
    Figure Indonesia Lou Gehrigs Disease Sales Growth Rate (2016-2025) (K Units)
    Figure Indonesia Lou Gehrigs Disease Revenue Growth Rate (2016-2025) (Million US$)
    Figure Malaysia Lou Gehrigs Disease Sales Growth Rate (2016-2025) (K Units)
    Figure Malaysia Lou Gehrigs Disease Revenue Growth Rate (2016-2025) (Million US$)
    Figure Philippines Lou Gehrigs Disease Sales Growth Rate (2016-2025) (K Units)
    Figure Philippines Lou Gehrigs Disease Revenue Growth Rate (2016-2025) (Million US$)
    Figure Thailand Lou Gehrigs Disease Sales Growth Rate (2016-2025) (K Units)
    Figure Thailand Lou Gehrigs Disease Revenue Growth Rate (2016-2025) (Million US$)
    Figure Vietnam Lou Gehrigs Disease Sales Growth Rate (2016-2025) (K Units)
    Figure Vietnam Lou Gehrigs Disease Revenue Growth Rate (2016-2025) (Million US$)
    Figure Singapore Lou Gehrigs Disease Sales Growth Rate (2016-2025) (K Units)
    Figure Singapore Lou Gehrigs Disease Revenue Growth Rate (2016-2025) (Million US$)
    Table Asia Pacific Lou Gehrigs Disease Sales by Type (2016-2025) (K Units)
    Table Asia Pacific Lou Gehrigs Disease Sales Market Share by Type (2016-2025)
    Figure 2017 Asia Pacific Lou Gehrigs Disease Market Share by Type
    Table Asia Pacific Lou Gehrigs Disease Sales by Application (2016-2025) (K Units)
    Table Asia Pacific Lou Gehrigs Disease Sales Market Share by Application (2016-2025)
    Figure 2017 Asia Pacific Lou Gehrigs Disease Market Share by Application
    Table Asia Pacific Lou Gehrigs Disease Sales by Company (2016-2018) (K Units)
    Table Asia Pacific Lou Gehrigs Disease Sales Market Share by Company (2016-2018)
    Figure Asia Pacific Lou Gehrigs Disease Sales Market Share by Company in 2017
    Figure Central & South America Lou Gehrigs Disease Sales Growth Rate 2016-2025 (K Units)
    Figure Central & South America Lou Gehrigs Disease Revenue Growth Rate 2016-2025 (Million US$)
    Table Central & South America Lou Gehrigs Disease Sales by Countries (2016-2025) (K Units)
    Table Central & South America Lou Gehrigs Disease Sales Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Lou Gehrigs Disease Sales Market Share by Countries
    Table Central & South America Lou Gehrigs Disease Revenue by Countries (2016-2025) (Million US$)
    Table Central & South America Lou Gehrigs Disease Revenue Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Lou Gehrigs Disease Revenue Market Share by Countries
    Figure Brazil Lou Gehrigs Disease Sales Growth Rate (2016-2025) (K Units)
    Figure Brazil Lou Gehrigs Disease Revenue Growth Rate (2016-2025) (Million US$)
    Figure Argentina Lou Gehrigs Disease Sales Growth Rate (2016-2025) (K Units)
    Figure Argentina Lou Gehrigs Disease Revenue Growth Rate (2016-2025) (Million US$)
    Table Central & South America Lou Gehrigs Disease Sales by Type (2016-2025) (K Units)
    Table Central & South America Lou Gehrigs Disease Sales Market Share by Type (2016-2025)
    Figure 2017 Central & South America Lou Gehrigs Disease Market Share by Type
    Table Central & South America Lou Gehrigs Disease Sales by Application (2016-2025) (K Units)
    Table Central & South America Lou Gehrigs Disease Sales Market Share by Application (2016-2025)
    Figure 2017 Central & South America Lou Gehrigs Disease Market Share by Application
    Table Central & South America Lou Gehrigs Disease Sales by Company (2016-2018) (K Units)
    Table Central & South America Lou Gehrigs Disease Sales Market Share by Company (2016-2018)
    Figure Central & South America Lou Gehrigs Disease Sales Market Share by Company in 2017
    Figure Middle East and Africa Lou Gehrigs Disease Sales Growth Rate 2016-2025 (K Units)
    Figure Middle East and Africa Lou Gehrigs Disease Revenue Growth Rate 2016-2025 (Million US$)
    Table Middle East and Africa Lou Gehrigs Disease Sales by Countries (2016-2025) (K Units)
    Table Middle East and Africa Lou Gehrigs Disease Sales Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Lou Gehrigs Disease Sales Market Share by Countries
    Table Middle East and Africa Lou Gehrigs Disease Revenue by Countries (2016-2025) (Million US$)
    Table Middle East and Africa Lou Gehrigs Disease Revenue Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Lou Gehrigs Disease Revenue Market Share by Countries
    Figure GCC Countries Lou Gehrigs Disease Sales Growth Rate (2016-2025) (K Units)
    Figure GCC Countries Lou Gehrigs Disease Revenue Growth Rate (2016-2025) (Million US$)
    Figure Turkey Lou Gehrigs Disease Sales Growth Rate (2016-2025) (K Units)
    Figure Turkey Lou Gehrigs Disease Revenue Growth Rate (2016-2025) (Million US$)
    Figure Egypt Lou Gehrigs Disease Sales Growth Rate (2016-2025) (K Units)
    Figure Egypt Lou Gehrigs Disease Revenue Growth Rate (2016-2025) (Million US$)
    Figure South Africa Lou Gehrigs Disease Sales Growth Rate (2016-2025) (K Units)
    Figure South Africa Lou Gehrigs Disease Revenue Growth Rate (2016-2025) (Million US$)
    Table Middle East and Africa Lou Gehrigs Disease Sales by Type (2016-2025) (K Units)
    Table Middle East and Africa Lou Gehrigs Disease Sales Market Share by Type (2016-2025)
    Figure 2017 Middle East and Africa Lou Gehrigs Disease Market Share by Type
    Table Middle East and Africa Lou Gehrigs Disease Sales by Application (2016-2025) (K Units)
    Table Middle East and Africa Lou Gehrigs Disease Sales Market Share by Application (2016-2025)
    Figure 2017 Middle East and Africa Lou Gehrigs Disease Market Share by Application
    Table Middle East and Africa Lou Gehrigs Disease Sales by Company (2016-2018) (K Units)
    Table Middle East and Africa Lou Gehrigs Disease Sales Market Share by Company (2016-2018)
    Figure Middle East and Africa Lou Gehrigs Disease Sales Market Share by Company in 2017
    Table AB Science Company Details
    Table AB Science Lou Gehrigs Disease Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table AB Science Recent Development
    Table Avicena Group Company Details
    Table Avicena Group Lou Gehrigs Disease Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Avicena Group Recent Development
    Table Biogen Company Details
    Table Biogen Lou Gehrigs Disease Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Biogen Recent Development
    Table BrainStorm Therapeutics Company Details
    Table BrainStorm Therapeutics Lou Gehrigs Disease Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table BrainStorm Therapeutics Recent Development
    Table Covis Pharmaceutical Inc. Company Details
    Table Covis Pharmaceutical Inc. Lou Gehrigs Disease Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Covis Pharmaceutical Inc. Recent Development
    Table Cytokinetics Inc. Company Details
    Table Cytokinetics Inc. Lou Gehrigs Disease Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Cytokinetics Inc. Recent Development
    Table Eisai Co. Ltd. Company Details
    Table Eisai Co. Ltd. Lou Gehrigs Disease Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Eisai Co. Ltd. Recent Development
    Table GlaxoSmithKline plc. Company Details
    Table GlaxoSmithKline plc. Lou Gehrigs Disease Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table GlaxoSmithKline plc. Recent Development
    Table Ionis Pharmaceuticals, Inc. Company Details
    Table Ionis Pharmaceuticals, Inc. Lou Gehrigs Disease Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Ionis Pharmaceuticals, Inc. Recent Development
    Table Mitsubishi Tanabe Pharma Corp. Company Details
    Table Mitsubishi Tanabe Pharma Corp. Lou Gehrigs Disease Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Mitsubishi Tanabe Pharma Corp. Recent Development
    Table Neuralstem Inc. Company Details
    Table Neuraltus Pharmaceuticals Inc. Company Details
    Table Newron Pharmaceuticals S.p.A. Company Details
    Table Nutra Pharma Corp. Company Details
    Table Pharnext SAS Company Details
    Table Q-Therapeutics Inc. Company Details
    Figure GDP by Regions / Largest Economies Pie Chart in 2016
    Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
    Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
    Figure Saving Rate Total, % of GDP, 2015
    Table Lou Gehrigs Disease Value Chain
    Table Typical Suppliers of Key Lou Gehrigs Disease Raw Material
    Table Lou Gehrigs Disease Customers List
    Table Lou Gehrigs Disease Sales Channels
    Table Lou Gehrigs Disease Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

 Select a Format



 Buy Now

24/7 Customer Support

Have questions?

Direct
+1-386-310-3803
Toll Free
+1-855-465-4651
sales@e-marketresearch.com